基于多多巴胺的工程介质性潜在性STING通路激活,用于先进的抗生物膜治疗
Shicheng Huo1, Zhuocheng Lyu2, Xiaoyuan Wang3
1Department of Orthopedic Surgery, Spine Center, Changzheng Hospital, Navy Medical University, Shanghai, China.
Biomaterials
|August 3, 2024
概括
这项研究开发了类似M1的巨细胞膜涂层纳米粒子 (m-Mncp) 来准和破坏生物膜. 这种免疫疗法方法可以增强免疫反应,并为耐火性感染提供抗生素的有希望的替代方案.
科学领域:
- 生物材料科学 生物材料科学
- 免疫治疗是一种免疫疗法.
- 纳米技术纳米技术
背景情况:
- 生物膜感染会产生免疫抑制的微环境,导致耐火性骨科感染.
- 操纵免疫细胞信号是生物膜管理的一个关键策略.
- 目前的抗生素治疗面临的挑战是生物膜的持久性.
研究的目的:
- 开发一种用于有针对性的生物膜破坏和免疫调节的新型纳米粒子系统.
- 研究M1-类巨细胞膜涂层纳米颗粒 (m-Mncp) 在治疗生物膜感染中的有效性.
- 探索m-Mncp作为传统抗生素治疗的替代方案.
主要方法:
- 将Mn2+和cGAMP (STING激活剂) 纳入中孔多巴胺纳米粒子 (Mnp).
- Mnp的外包装与M1-类巨细胞膜形成m-Mncp.
- 使用光热和光动力学疗法用于生物膜破坏和抗原暴露.
- 评估免疫细胞的调节,包括APC,T细胞和MDSC.
主要成果:
- m-Mncp在感染部位表现出增强的向和积累.
- 结合光热和光动力学疗法有效地破坏了生物膜并诱导了抗原呈现.
- 免疫疗法调节免疫抑制,增强APC并启动T细胞反应.
- 观察到抑制髓质衍生抑制细胞 (MDSC) 和增强T细胞活性.
结论:
- 与光热/光动力疗法相结合的m-Mncp免疫疗法有效地减轻了残留和复发的生物膜感染.
- 这种方法显示出治疗具有挑战性的骨科感染的潜力.
- 这项研究为反抗性生物膜提供了传统抗生素治疗的可行替代方案.
相关概念视频
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160
01:29Biofilms
2.1K
Biofilms are complex communities of microorganisms encased in a self-produced extracellular polysaccharide matrix attached to surfaces. These microbial consortia can include single or multiple species, providing enhanced survival benefits by forming organized, multilayered structures.The formation of biofilms occurs through four key stages: attachment, colonization, development, and dispersal.During attachment, free-swimming planktonic cells adhere to a surface, often facilitated by...
2.1K